Dr Reddys Laboratories (RDY) Common Equity (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Common Equity of $4.1 billion for Q1 2026, up 3.87% year-over-year from $3.9 billion in Q1 2025, and up 3.87% quarter-over-quarter from $3.9 billion in Q1 2025.
Dr Reddys Laboratories (RDY) Common Equity (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Common Equity history runs 16 years deep, the most recent figure standing at $4.1 billion for Q1 2026.
- In Q1 2026, Common Equity rose 3.87% year-over-year to $4.1 billion; the TTM figure through Mar 2026 stood at $4.1 billion (up 3.87% YoY), while the FY2026 annual figure was $4.1 billion, up 3.87% from the prior year.
- Common Equity for Q1 2026 stood at $4.1 billion, up from $3.9 billion in the prior quarter.
- The five-year high for Common Equity was $4.1 billion in Q1 2026, with the low at $2.4 billion in Q2 2022.
- The 4-year median for Common Equity is $3.0 billion (2023), against an average of $3.2 billion.
- The sharpest annual moves came in 2023 and 2026: Common Equity increased 22.4% in 2023, then grew 3.87% in 2026.
- Dr Reddys Laboratories' Common Equity stood at $2.4 billion in 2022, then climbed by 22.4% to $3.0 billion in 2023, then soared by 30.58% to $3.9 billion in 2025, then increased by 3.87% to $4.1 billion in 2026.
- Business Quant data shows RDY's Common Equity at $4.1 billion in Q1 2026, $3.9 billion in Q1 2025, and $3.0 billion in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 1.81 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.05 Bn |
| Mar 31, 2025 | 3.90 Bn |
| Jun 30, 2023 | 2.99 Bn |
| Mar 31, 2023 | 2.82 Bn |
| Jun 30, 2022 | 2.44 Bn |
| Dec 31, 2020 | 2.32 Bn |
| Sep 30, 2020 | 2.27 Bn |
| Dec 31, 2019 | 2.04 Bn |
| Sep 30, 2019 | 2.16 Bn |
| Dec 31, 2018 | 1.90 Bn |
| Jun 30, 2018 | 1.91 Bn |
| Mar 31, 2018 | 1.85 Bn |
| Dec 31, 2017 | 1,938.00 |
| Sep 30, 2017 | 1,909.00 |
| Jun 17, 2017 | 1.91 Bn |
| Mar 17, 2017 | 1.92 Bn |
| Dec 31, 2016 | 1,782.00 |
| Sep 30, 2016 | 1,697.00 |
| Jun 16, 2016 | 1.69 Bn |
| Dec 31, 2015 | 1.94 Bn |